Prognostic indicators in node-negative breast cancer.

Prognostic indicators in node-negative breast cancer.

Prognostic indicators in invasive breast cancer.

Computational prognostic indicators for breast cancer.

Prognostic indicators in metastatic prostate cancer.

6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.

Differential prognostic indicators for locoregional recurrence, distant recurrence, and death of breast cancer.

p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

Prognostic factors in breast cancer.



Prognostic indicators in femoropopliteal reconstructions.

DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.

Prognostic stromal gene signatures in breast cancer.

Prognostic value of morphometry in breast cancer.

Prognostic models in male breast cancer.

Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators.

Indicators of distress in newly diagnosed breast cancer patients.

Indicators of prognosis in node-negative breast cancer.

Prognostic indicators in cats with hypertrophic cardiomyopathy.

Serum prognostic indicators in experimental Bacteroides peritonitis.

Prognostic indicators in patients with pulmonary metastases.

Breast cancer prognostic factors: evaluation guidelines.

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

Suggest Documents

Prognostic indicators in node-negative breast cancer.

Prognostic indicators in invasive breast cancer.

Computational prognostic indicators for breast cancer.

Prognostic indicators in metastatic prostate cancer.

6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.

Differential prognostic indicators for locoregional recurrence, distant recurrence, and death of breast cancer.

p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

Prognostic factors in breast cancer.

Prognostic factors in breast cancer.

Prognostic factors in breast cancer.

Prognostic indicators in femoropopliteal reconstructions.

DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.

Prognostic stromal gene signatures in breast cancer.

Prognostic value of morphometry in breast cancer.

Prognostic models in male breast cancer.

Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators.

Indicators of distress in newly diagnosed breast cancer patients.

Indicators of prognosis in node-negative breast cancer.

Prognostic indicators in cats with hypertrophic cardiomyopathy.

Serum prognostic indicators in experimental Bacteroides peritonitis.

Prognostic indicators in patients with pulmonary metastases.

Breast cancer prognostic factors: evaluation guidelines.

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.

Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?

Prognostic indicators in node-negative breast cancer.

Recommend Documents

Follow Us